A Phase 3, Long-term, Open-label Study of Istradefylline in subjects with moderate to Severe Parkinson's Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Kyowa Hakko Kirin Pharma Co, Ltd.
Start Date
January 1, 2016
End Date
December 31, 2018
Administered By
Neurology, Movement Disorders
Awarded By
Kyowa Hakko Kirin Pharma Co, Ltd.
Start Date
January 1, 2016
End Date
December 31, 2018